Targeted axillary dissection

PROCEDURE3 trials

Sponsors

University Hospital Ostrava, Jewish General Hospital, Karolinska Institutet

Conditions

Axillary MetastasesBreast CancerBreast Cancer FemaleBreast CarcinomaBreast SurgeryEarly-stage Breast CancerLymph Node MetastasesSentinel Lymph Node

Unknown Phase

Ideal Marker for Targeted Axillary Dissection

CompletedNCT04580251

University Hospital OstravaBreast Cancer

Start: 2021-01-01End: 2023-05-30Updated: 2023-09-07

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

RecruitingNCT04671511

Jewish General HospitalAxillary Metastases, Breast Cancer Female, Early-stage Breast Cancer +2

Start: 2021-03-30End: 2026-07-31Target: 98Updated: 2025-02-20

Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer

Not yet recruitingNCT06869629

Karolinska InstitutetBreast Cancer, Breast Carcinoma, Breast Surgery

Start: 2026-01-01End: 2040-12-31Target: 1380Updated: 2025-12-05

Related Papers

Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial.

2023-08-1913 citations